<DOC>
	<DOC>NCT01942200</DOC>
	<brief_summary>The main purpose of this observational study with Oxaliplatin onkovis is to determine the number of treatment cycles and the quantity of Oxaliplatin onkovis needed for this purpose under the special circumstances of ambulant chemotherapy. Onkovis aims to contribute to an economical utilization of the chemotherapeutics. This includes provision of appropriate packaging sizes to decrease the excess quantity to be discarded, and thus also follows this objective. Secondary objective is the assessment of the side effects of Oxaliplatin onkovis. To this end, data regarding co-medication and adverse events are also collected.</brief_summary>
	<brief_title>A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Indication for Oxaliplatin according to the Summary of Product Characteristics (SmPC) and treating physician According to the Oxaliplatin SmPC</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>carcinoma</keyword>
	<keyword>colon cancer</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>ambulant chemotherapy</keyword>
	<keyword>treatment cycles</keyword>
	<keyword>Oxaliplatin</keyword>
	<keyword>Oxaliplatin onkovis</keyword>
	<keyword>Quantity of Oxaliplatin</keyword>
	<keyword>Packaging Sizes</keyword>
</DOC>